GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (NAS:TLRY) » Definitions » Cyclically Adjusted PB Ratio

Tilray Brands (Tilray Brands) Cyclically Adjusted PB Ratio : 0.37 (As of Apr. 27, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Tilray Brands Cyclically Adjusted PB Ratio?

As of today (2024-04-27), Tilray Brands's current share price is $1.78. Tilray Brands's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2024 was $4.77. Tilray Brands's Cyclically Adjusted PB Ratio for today is 0.37.

The historical rank and industry rank for Tilray Brands's Cyclically Adjusted PB Ratio or its related term are showing as below:

TLRY' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.34   Med: 0.74   Max: 4.72
Current: 0.37

During the past years, Tilray Brands's highest Cyclically Adjusted PB Ratio was 4.72. The lowest was 0.34. And the median was 0.74.

TLRY's Cyclically Adjusted PB Ratio is ranked better than
89.03% of 647 companies
in the Drug Manufacturers industry
Industry Median: 1.75 vs TLRY: 0.37

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Tilray Brands's adjusted book value per share data for the three months ended in Feb. 2024 was $4.339. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $4.77 for the trailing ten years ended in Feb. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Tilray Brands Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Tilray Brands's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tilray Brands Cyclically Adjusted PB Ratio Chart

Tilray Brands Annual Data
Trend Aug14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.20 0.38

Tilray Brands Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.38 0.65 0.39 0.36

Competitive Comparison of Tilray Brands's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tilray Brands's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Tilray Brands's Cyclically Adjusted PB Ratio falls into.



Tilray Brands Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Tilray Brands's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.78/4.77
=0.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tilray Brands's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2024 is calculated as:

For example, Tilray Brands's adjusted Book Value per Share data for the three months ended in Feb. 2024 was:

Adj_Book=Book Value per Share/CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=4.339/125.4675*125.4675
=4.339

Current CPI (Feb. 2024) = 125.4675.

Tilray Brands Quarterly Data

Book Value per Share CPI Adj_Book
201405 0.358 99.394 0.452
201408 0.339 99.315 0.428
201411 0.305 99.078 0.386
201502 0.249 99.078 0.315
201505 0.244 100.263 0.305
201508 0.222 100.579 0.277
201511 0.217 100.421 0.271
201602 0.375 100.421 0.469
201605 0.457 101.765 0.563
201608 0.728 101.686 0.898
201611 1.019 101.607 1.258
201702 1.381 102.476 1.691
201705 1.750 103.108 2.130
201708 1.977 103.108 2.406
201711 2.370 103.740 2.866
201802 3.869 104.688 4.637
201805 5.125 105.399 6.101
201808 5.694 106.031 6.738
201811 6.390 105.478 7.601
201902 6.095 106.268 7.196
201905 5.990 107.927 6.963
201908 6.118 108.085 7.102
201911 6.140 107.769 7.148
202002 6.125 108.559 7.079
202005 5.197 107.532 6.064
202008 5.713 108.243 6.622
202011 5.491 108.796 6.332
202102 4.457 109.745 5.096
202105 9.988 111.404 11.249
202108 9.588 112.668 10.677
202111 9.565 113.932 10.533
202202 9.625 115.986 10.412
202205 8.258 120.016 8.633
202208 7.530 120.569 7.836
202211 7.290 121.675 7.517
202302 5.509 122.070 5.662
202305 5.049 124.045 5.107
202308 4.672 125.389 4.675
202311 4.596 125.468 4.596
202402 4.339 125.468 4.339

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tilray Brands  (NAS:TLRY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Tilray Brands Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Tilray Brands's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tilray Brands (Tilray Brands) Business Description

Address
265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol.
Executives
Denise M Faltischek officer: Chief Strategy Officer C/O THE HAIN CELESTIAL GROUP, INC., 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Mitchell Gendel officer: Global General Counsel EMERALD HOLDING, INC., 100 BROADWAY, 14TH FLOOR, NEW YORK NY 10005
Irwin D Simon director, officer: President & CEO C/O THE HAIN CELESTIAL GROUP INC., 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Carl A Merton officer: Chief Financial Officer C/O TILRAY, INC., 745 FIFTH AVENUE, SUITE 1602, NEW YORK NY 10151
Brendan Kennedy director 1920 EASTLAKE AVENUE E., SEATTLE WA 98105
James R. Meiers officer: Head of Canada C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
David G. Hopkinson director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Thomas P. Looney director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Johann Michael Herhalt director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Jodi L. Butts director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
David F Clanachan director TIM HORTONS INC., 874 SINCLAIR ROAD, OAKVILLE A6 L6K 2Y1
Renah Persofsky director 55 PRINCE ARTHUR AVENUE, #604, TORONTO A6 M5R 1B3
Jon Edward Levin officer: Chief Operating Officer 2701 EASTLAKE AVE E, 3RD FLOOR, SEATTLE WA 98102
Michael C. Kruteck officer: Chief Financial Officer 2701 EASTLAKE AVE E, 3RD FLOOR, SEATTLE WA 98102
Rebekah Dopp director 444 LENOX AVENUE, SOUTH ORANGE NJ 07079